Premier Pharmacy Labs IncJune 13, 2016

FDA 483 - Premier Pharmacy Labs Inc - June 13, 2016

FDA 483 for Premier Pharmacy Labs Inc on June 13, 2016. Product: Drugs. Access full analysis and detailed observations.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 483 for Premier Pharmacy Labs Inc on June 13, 2016. Product: Drugs. Access full analysis and detailed observations.

Violation Codes

21 CFR 207.20(a)(2)

21 CFR 820.90

21 U.S.C. 351(b)

FD&C Act 801(a)(3)

21 U.S.C. 331(c)

21 CFR 211.132(b)

FD&C Act 503B(a)(2)(A)

21 CFR 211

FD&C Act 503B(a)(10)(B)

21 U.S.C. 353b(a)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Premier Pharmacy Labs Inc

Inspection Date

June 13, 2016

Product Type

Drugs

Office

Florida District Office

People

ID: a5844294-7a9c-4e4b-9a2b-bf67907c4561

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox